Refractory and Relapsed T Cell Lymphoma
1 clinical trials · Condition
◉ Watch Refractory and Relapsed T Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma (NCT05059912) | The First Affiliated Hospital of Soochow University | 2021-08-05 |
Track Refractory and Relapsed T Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.